An interventional study of Nanofat grafting in Androgenic Alopecia, sponsored by Jinan University Guangzhou. Completed at 1 site in China. Open to male participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-02-21.
Sponsored by Jinan University Guangzhou · Not applicable, Interventional, and Treatment
Nowadays, multiple treatment modalities have been applied clinically to treat androgenic alopecia, such as Follicular unit transplantation(FUT), finasteride, platelet-rich plasma injection(PRP), etc. In this clinical trial, the investigators aim to analyze the effect of nanofat grafting on treating androgenic alopecia in male.
The investigators will treat the hair loss area of a patient by processed nanofat grafting. The participants were asked to come back 1、3、6、9、12 months after treatment for further follow-up.
Before and after the treatment, the hair and follicular will be assessed subjectively by satisfaction assessment, dermatoscope.
615 studies on the registry are indexed under Alopecia; 132 are open to participants now.
This study's enrollment of 10 is below the median of 45 across 516 interventional studies indexed under Alopecia.
Browse Alopecia studies →Jinan University Guangzhou is the lead sponsor of 14 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
processed autologous Nanofat will be injected into the area of the scalp with androgenic alopecia.
Procedure: Nanofat grafting
hair loss area will be treated by processed autologous Nanofat grafting
Dermatoscope
the density of hair follicle and diameter of hair will be analized by dermatoscope before and after the treatment of Nanofat grafting.
Time frame: Baseline and at1,3,6,9,12 months after the treatment
Satisfaction assessments
the satisfaction will be assessed after the treatment
Time frame: 1,3,6,12 months after treatment
Plan to share: No
Ran from Feb 2019 to primary completion in Feb 2020, 12 months.
Of 96 non-industry interventional studies with no phase under Alopecia, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 39. This study's 12 months is close to that.
Counting every sponsor, half of 154 studies reached it within 12 months; a quarter within 6 and three quarters within 26.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Jinan University Guangzhou